Apr. 17 at 1:27 PM
$GPCR Doesn't look like the market priced it in, but I do like the hire of former
$MTSR Chief Legal Officer. I think this is a strong move.
While I think previous company ties are often over inflated, this hire appears very pertinent to what
$GPCR needs at this point.
A snippet from the Structure Press Release:
"Mr. Lang most recently served as Chief Legal Officer and Secretary at Metsera, Inc., helping to guide the company through its up to
$10 billion acquisition by Pfizer. Prior to Metsera, Mr. Lang served as Chief Business and Legal Officer at Lyell Immunopharma, Inc., and held several executive officer positions at Myovant Sciences, where he helped lead the company through Phase 3 clinical development, global approval and commercialization of Myfembree® and Orgovyx®."
Welcome aboard Mr. Lang!
https://ir.structuretx.com/news-releases/news-release-details/structure-therapeutics-appoints-matthew-lang-jd-chief-operating
